CUSTOMER PORTALPharmaceutical & Life Sciences – Risk Management & Compliance Solutions
35% of the Global Pharmaceutical Market Runs on Aravo
Supplier, vendor, and third-party risk management (TPRM) solutions that enable you to focus on delivering quality of life, not on a broken supply chain.
Third-Party Risk Management for Pharma & Life Sciences Compliance
According to KPMG’s 2026 Global TPRM survey, the top challenges for senior leaders include monitoring third-party performance, developing contingency plans for critical suppliers, and ensuring sufficient internal resources.
These pressures reflect an environment where third-party risk directly affects patient safety, product quality, regulatory compliance, and treatment availability—where even a single disruption or compliance failure can delay trials, trigger regulatory action, or restrict access to therapies.
Organizations must manage complex global supplier ecosystems while meeting requirements, including:
- FDA and EMA regulations
- GMP / GxP standards
- HIPAA / HITECH compliance
- Anti-Bribery / FCPA requirements
- ESG / Scope 3 reporting
KPMG’s 2026 Global TPRM Survey
Over 800 senior leaders across 16 countries in life sciences, reported the following challenges:
19%
Monitoring third-party performance
18%
Designing contingency plans for critical suppliers
18%
Ensuring sufficient internal resources
Aravo’s Intelligence First™ Platform for TPRM, with native, embedded AI, delivers clarity, control, and speed across the full third-party lifecycle—from intake and onboarding to due diligence, performance management, and offboarding.
A Unified Platform
for Every Critical
Risk Domain
Aravo helps pharma and life sciences organizations manage risk across foundational and highly specialized domains through a centralized platform.
Whether assessing operational, financial, reputational, cybersecurity, privacy, or compliance risk—or addressing unique industry requirements such as pharmacovigilance—Aravo enables a consistent, scalable approach across the entire third-party ecosystem.
Support specialized processes such as:
Adverse event reporting
Safety signal detection
Post-market monitoring
Regulatory documentation oversight
Third-party quality controls
We enable teams to replace fragmented spreadsheets, siloed tools, and manual reviews with a single source of truth for third-party risk.
Native AI that Understands Your Third-Party Ecosystem
Aravo AI is natively embedded within the Intelligence First™ Platform to enhance every stage of third-party risk management. Whether managing suppliers, manufacturers, distributors, CROs, sales intermediaries, or service providers, Aravo AI employs:
AI Canvas with Interactive Agents
Gain real-time insight and interaction on supplier risk, GxP requirements, pharmacovigilance obligations, and third-party decisions
Workflow Agents
Automate time-consuming tasks such as reviewing onboarding documents, extracting regulatory data, and pre-filling due diligence questionnaires
And with Aravo’s no-code AI Studio for customization and control, teams can create and configure their own AI Catalog for life sciences use cases unique to their organization—such as monitoring changing pharmacovigilance regulations or guiding consistent third-party decisions across business units.
Built for Pharma Complexity. Designed for Risk Team Confidence.
TPRM teams need to evaluate multiple risk domains at once. Aravo simplifies that complexity with pre-built applications for key risk areas, including:
-
- Cybersecurity
- Data Privacy
- Anti-Bribery & Corruption (ABAC)
- ESG
- Financial Risk
For specialized needs such as pharmacovigilance or quality oversight, Aravo also provides Customer-Defined Assessments (CDAs) that allow organizations to tailor due diligence processes to specific requirements.
Today, Aravo supports 50+ risk domains across its customer community, including many leading highly regulated enterprises.
See Risk Clearly. Score It Confidently. Act Faster.
Third-party risk goes beyond a single score. Suppliers, CROs, distributors, and service providers can create exposure across engagements, performance, compliance, privacy, cybersecurity, and product quality.
Aravo’s Evaluate Engine, a core component of the Intelligence First™ Platform, delivers configurable risk scoring across every level that matters:
-
- Third parties
- Engagements
- Individual risk domains
- Aggregate enterprise exposure
- Ongoing performance trends
Using flexible scoring models aligned with your policies and risk appetite, teams can prioritize more quickly, improve consistency, and make regulator-ready decisions with confidence.
Aravo turns risk scoring into a dynamic decision engine for modern pharma and life sciences organizations.
Designed for an Industry Where
There’s No Margin
for Error
Aravo delivers the visibility, intelligence, and control Pharma & Life Sciences organizations need to manage third-party risk, maintain compliance, and support resilient global operations.
Pharma and Life Sciences Risk & Compliance Performance Benchmarks
Third Parties
20,365
Internal Users
12,081
Monthly Processes Initiated
2,763
Third Party
Registration
Engagement
Management
ABAC
Information
Security
Data
Privacy
